Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104177394B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104177394B reveals a cost-effective Entecavir intermediate route with mild conditions, offering supply chain stability and high purity for antiviral drug production.